Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Elixinol Wellness ( (AU:EXL) ) is now available.
Elixinol Wellness has lodged its latest corporate governance statement for the financial year ended 31 December 2025, confirming that the statement is current as of 27 February 2026 and has been approved by the board. The company has opted to publish the statement on its website and has filed the accompanying Appendix 4G, outlining how it complies with ASX Corporate Governance Council principles, including board charters, director appointment processes and executive agreements, reinforcing transparency and governance standards for investors.
The lodgement demonstrates Elixinol’s ongoing compliance with ASX listing requirements, signalling to shareholders and regulators that it maintains structured oversight and clear delineation of board and management responsibilities. By formally documenting its governance practices and making them accessible online, the company aims to support investor confidence and provide a clear verification tool for stakeholders assessing its governance framework.
The most recent analyst rating on (AU:EXL) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on Elixinol Wellness stock, see the AU:EXL Stock Forecast page.
More about Elixinol Wellness
Elixinol Wellness Limited is an ASX-listed company operating in the wellness sector, with a focus on products and services aligned to health and wellbeing markets. The company is subject to the Australian Securities Exchange corporate governance framework and reports annually on its adherence to ASX Corporate Governance Council principles and recommendations.
Average Trading Volume: 766,139
Technical Sentiment Signal: Sell
Current Market Cap: A$4.14M
For a thorough assessment of EXL stock, go to TipRanks’ Stock Analysis page.